Imaging glucose metabolism to reveal tumor progression
Open accessThe DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Abstract
Purpose: To analyze and review the progress of glucose metabolism-based molecular imaging in detecting tumors to guide clinicians for new management strategies. Summary: When metabolic abnormalities occur, termed the Warburg effect, it simultaneously enables excessive cell proliferation and inhibits cell apoptosis. Molecular imaging technology combines molecular biology and cell probe technology to visualize, characterize, and quantify processes at cellular and subcellular levels in vivo. Modern instruments, including molecular biochemistry, data processing, nanotechnology, and image processing, use molecular probes to perform real-time, non-invasive imaging of molecular and cellular events in living organisms. Conclusion: Molecular imaging is a non-invasive method for live detection, dynamic observation, and quantitative assessment of tumor glucose metabolism. It enables in-depth examination of the connection between the tumor microenvironment and tumor growth, providing a reliable assessment technique for scientific and clinical research. This new technique will facilitate the translation of fundamental research into clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![FIGURE 2 Overview of glycolysis routes detectable with various imaging techniques. PET with 18F-FDG may detect glucose uptake; MRS with 13C-Glucose can be used for optical imaging. Pyruvate kinase M2 (PKM2) is detectable with PET utilizing [18F]DASA-23, [18F]FDG, and [11C]DASA-23. Contribution of pyruvate and lactate may be assessed using 13C-Pyruvate and 13C-Lactate utilizing MRS. Combining imaging modalities with quantitative immunohistochemistry allows the assessment of total protein levels and phosphorylation.](https://figures.cochat.ai/paper-figures/08d2895181234e67851c730d9cf114aa/imaging-glucose-metabolism-to-reveal-tumor-progression-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other imaging modalities based on increased glucose uptake such as using [1–13C] glucose or [6,6-2H2]glucose magnetic resonance spectroscopy, or using tracers based on other indicators of glycolysis such as increased lactate production have also been utilized or are currently under development [53, 54].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [53]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Artificial intelligence in cancer imaging: Clinical challenges and applications
Bi, W. L., Hosny, A., Schabath, M. B., Giger, M. L., Birkbak, N. J., Mehrtash, A., Allison, T., Arnaout, O., Abbosh, C., Dunn, I. F., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21552 · Cited by 1,846 · cited 1×
“In addition, a unique software algorithm, “Glyoxia,” has been developed (Bi et al., 2019; Moscoso et al., 2019), which can detect glycolysis and hypoxia through the automatic processing of 18F-FDG and 18F-FMISO PET images.”
MethodFantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635 · cited 1×
“Therefore, after the injection of HP [1-13C] pyruvate, rapid 13C MR was used to measure the metabolic conversion of this aggressive cancer and its response to treatment, with direct biological significance (Fantin et al., 2006; Keshari et al., 2013a; Keshari et al., 2013b; Wilson and Kurhanewicz, 2014).”
MethodThe cancer metabolic reprogramming and immune response
Xia, L., Oyang, L., Lin, J., Tan, S., Han, Y., Wu, N., Yi, P., Tang, L., Pan, Q., Rao, S., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01316-8 · Cited by 1,312
Metabolic regulation of cell growth and proliferation
Zhu, J., & Thompson, C. B. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0123-5 · Cited by 1,116
Science Translational Medicine
(2013) · Science Translational Medicine · doi:10.1126/scitranslmed · Cited by 859
Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
Kraehenbuehl, L., Weng, C.-H., Eghbali, S., Wolchok, J. D., & Merghoub, T. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00552-7 · Cited by 846
Spatial omics and multiplexed imaging to explore cancer biology
Lewis, S. M., Asselin-Labat, M.-L., Nguyen, Q., Berthelet, J., Tan, X., Wimmer, V. C., Merino, D., Rogers, K. L., & Naik, S. H. (2021) · Nature Methods · doi:10.1038/s41592-021-01203-6 · Cited by 619
Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα
Guo, D., Tong, Y., Jiang, X., Meng, Y., Jiang, H., Du, L., Wu, Q., Li, S., Luo, S., Li, M., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.08.002 · Cited by 423
Self-citationMicroRNA-mediated regulation of glucose and lipid metabolism
Agbu, P., & Carthew, R. W. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00354-w · Cited by 363
Molecular imaging in oncology: Current impact and future directions
Rowe, S. P., & Pomper, M. G. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21713 · Cited by 337
Insulin: The master regulator of glucose metabolism
Norton, L., Shannon, C., Gastaldelli, A., & DeFronzo, R. A. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155142 · Cited by 330
Vernieri, C., Fucà, G., Ligorio, F., Huber, V., Vingiani, A., Iannelli, F., Raimondi, A., Rinchai, D., Frigè, G., Belfiore, A., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0030 · Cited by 319 · cited 1×
“Immunotherapy replaces traditional radiotherapies and chemotherapies with immune checkpoint inhibitors, which use the patient’s immune system to identify and target cancer cells (Vernieri et al., 2022).”
BackgroundStewart, C. L., Warner, S., Ito, K., Raoof, M., Wu, G. X., Kessler, J., Kim, J. Y., & Fong, Y. (2018) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2018.08.004 · Cited by 287
Towards personalized treatment for early stage HER2-positive breast cancer
Goutsouliak, K., Veeraraghavan, J., Sethunath, V., De Angelis, C., Osborne, C. K., Rimawi, M. F., & Schiff, R. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0299-9 · Cited by 287
Diagnostic value of imaging in infective endocarditis: a systematic review
Gomes, A., Glaudemans, A. W. J. M., Touw, D. J., van Melle, J. P., Willems, T. P., Maass, A. H., Natour, E., Prakken, N. H. J., Borra, R. J. H., van Geel, P. P., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30141-4 · Cited by 277
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
Ambrosini, V., Kunikowska, J., Baudin, E., Bodei, L., Bouvier, C., Capdevila, J., Cremonesi, M., de Herder, W. W., Dromain, C., Falconi, M., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.01.008 · Cited by 244
Liang, C., Shi, S., Qin, Y., Meng, Q., Hua, J., Hu, Q., Ji, S., Zhang, B., Xu, J., & Yu, X.-J. (2020) · Gut · doi:10.1136/gutjnl-2018-317163 · Cited by 198
Kaira, K., Higuchi, T., Naruse, I., Arisaka, Y., Tokue, A., Altan, B., Suda, S., Mogi, A., Shimizu, K., Sunaga, N., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3806-1 · Cited by 195
The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma
Momcilovic, M., Bailey, S. T., Lee, J. T., Fishbein, M. C., Braas, D., Go, J., Graeber, T. G., Parlati, F., Demo, S., Li, R., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.04.002 · Cited by 181
Hexokinase 1 cellular localization regulates the metabolic fate of glucose
De Jesus, A., Keyhani-Nejad, F., Pusec, C. M., Goodman, L., Geier, J. A., Stoolman, J. S., Stanczyk, P. J., Nguyen, T., Xu, K., Suresh, K. V., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.02.028 · Cited by 181
Zamagni, E., Nanni, C., Dozza, L., Carlier, T., Bailly, C., Tacchetti, P., Versari, A., Chauvie, S., Gallamini, A., Gamberi, B., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00386 · Cited by 175
FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer
Lovinfosse, P., Polus, M., Van Daele, D., Martinive, P., Daenen, F., Hatt, M., Visvikis, D., Koopmansch, B., Lambert, F., Coimbra, C., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3855-5 · Cited by 165
Impact of cancer metabolism on therapy resistance – Clinical implications
Gonçalves, A. C., Richiardone, E., Jorge, J., Polónia, B., Xavier, C. P. R., Salaroglio, I. C., Riganti, C., Vasconcelos, M. H., Corbet, C., & Sarmento-Ribeiro, A. B. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100797 · Cited by 164
Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy
Rangel Rivera, G. O., Knochelmann, H. M., Dwyer, C. J., Smith, A. S., Wyatt, M. M., Rivera-Reyes, A. M., Thaxton, J. E., & Paulos, C. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.645242 · Cited by 140
Transpathology: molecular imaging-based pathology
Tian, M., He, X., Jin, C., He, X., Wu, S., Zhou, R., Zhang, X., Zhang, K., Gu, W., Wang, J., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05234-1 · Cited by 134
Zhao, G., Yuan, H., Qin, L., Zhang, J., Guo, Y., Feng, T., Gu, R. C., Ou, D., Li, S., Li, K., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01096-7 · Cited by 133
Usmanij, E. A., de Geus‐Oei, L., Troost, E. G. C., Peters-Bax, L., van der Heijden, E. H. F. M., Kaanders, J. H. A. M., Oyen, W. J. G., Schuurbiers, O. C. J., & Bussink, J. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.116921 · Cited by 130
Keshari, K. R., Sriram, R., Criekinge, M. V., Wilson, D. M., Wang, Z. J., Vigneron, D. B., Peehl, D. M., & Kurhanewicz, J. V. (2013) · The Prostate · doi:10.1002/pros.22665 · Cited by 115
Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis
Ouyang, X., Han, S.-N., Zhang, J.-Y., Dioletis, E., Nemeth, B. T., Pacher, P., Feng, D., Bataller, R., Cabezas, J., Stärkel, P., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.01.007 · Cited by 115
Pan, Q., Cao, X., Luo, Y., Li, J., Feng, J., & Li, F. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04605-z · Cited by 112
Wang, Y., Zhao, N., Wu, Z., Pan, N., Shen, X., Liu, T., Wei, F., You, J., Xu, W., & Ren, X. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04500-7 · Cited by 107
Keshari, K. R., Sriram, R., Koelsch, B. L., Criekinge, M. V., Wilson, D. M., Kurhanewicz, J. V., & Wang, Z. J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-3461 · Cited by 104
Global guidance for the recognition, diagnosis, and management of tumor‐induced osteomalacia
de Beur, S. M. J., Minisola, S., Xia, W., Abrahamsen, B., Body, J., Brandi, M. L., Clifton-Bligh, R. J., Collins, M. T., Florenzano, P. F., Houillier, P., et al. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13593 · Cited by 104
Targeting lactate-related cell cycle activities for cancer therapy
Lin, J. L., Liu, G., Chen, L., Kwok, H. F., & Lin, Y. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.009 · Cited by 101
Clinical advances in PET–MRI for breast cancer
Fowler, A. M., & Strigel, R. M. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00577-5 · Cited by 98
Ayati, N., Sadeghi, R., Kiamanesh, Z., Lee, S. T., Zakavi, S. R., & Scott, A. M. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04967-9 · Cited by 94
Mitochondrial dysfunction-targeted nanosystems for precise tumor therapeutics
Ma, Z., Han, H., & Zhao, Y. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121947 · Cited by 90
Fat Induces Glucose Metabolism in Nontransformed Liver Cells and Promotes Liver Tumorigenesis
Broadfield, L. A., Duarte, J. A. G., Schmieder, R., Broekaert, D., Veys, K., Planque, M., Vriens, K., Karasawa, Y., Napolitano, F., Fujita, S., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1954 · Cited by 83
Radiomic features of glucose metabolism enable prediction of outcome in mantle cell lymphoma
Mayerhoefer, M. E., Riedl, C. C., Kumar, A. A., Gibbs, P., Weber, M., Tal, I., Schilksy, J., & Schöder, H. M. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04420-6 · Cited by 82
Dezhakam, E., Khalilzadeh, B., Mahdipour, M., Işıldak, İ., Yousefi, H., Ahmadi, M., Naseri, A., & Rahbarghazi, R. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114980 · Cited by 74
Salavati, A., Duan, F., Snyder, B. S., Wei, B., Houshmand, S., Khiewvan, B., Opanowski, A., Simone, C. B., Siegel, B. A., Machtay, M. X., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3753-x · Cited by 72
Gao, L., Yang, F., Tang, D., Xu, Z., Tang, Y., Yang, D., Sun, D., Chen, Z., & Teng, Y. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02574-0 · Cited by 70
Tarumi, R., Tsugawa, S., Noda, Y., Plitman, E., Honda, S., Matsushita, K., Chavez, S., Sawada, K., Wada, M., Matsui, M., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0589-z · Cited by 69
Witney, T. H., James, M. L., Shen, B., Chang, E., Pohling, C., Arksey, N., Höhne, A., Shuhendler, A. J., Park, J. H., Bodapati, D., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac6117 · Cited by 67
Hyperpolarized 13C MR for Molecular Imaging of Prostate Cancer
Wilson, D. M., & Kurhanewicz, J. V. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.141705 · Cited by 67
Schwenck, J., Schörg, B. F., Fiz, F., Sonanini, D., Forschner, A., Eigentler, T., Weide, B., Martella, M., González-Menéndez, I., Campi, C., et al. (2019) · Theranostics · doi:10.7150/thno.35989 · Cited by 67
Santini, F., Mantovani, A., Cristaudo, A., Rago, T., Marsili, A., Buselli, R., Mignani, A., Ceccarini, G., Bastillo, R., Taddei, D., et al. (2008) · CINECA IRIS Institutial research information system (University of Pisa) · doi:10.1089/thy · Cited by 63
Elimova, E. C., Wang, X., Etchebehere, E., Shiozaki, H., Shimodaira, Y., Wadhwa, R., Planjery, V., Charalampakis, N., Blum, M. A., Hofstetter, W. L., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.07.044 · Cited by 59
Ayubcha, C., Revheim, M.-E. R., Newberg, A. B., Moghbel, M. C., Rojulpote, C., Werner, T. J., & Alavi, A. A. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04926-4 · Cited by 58
Liu, C., Lu, M., Liu, Y.-L., Ko, C., Ko, K., Tzen, K., Chang, H., Yang, Y., Jou, S., Hsu, W., et al. (2017) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001529 · Cited by 53
Sachpekidis, C., Larribère, L., Kopp‐Schneider, A., Hassel, J. C., & Dimitrakopoulou‐Strauss, A. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2279-9 · Cited by 53
Wong, K. H., Panek, R., Welsh, L. C., Mcquaid, D., Dunlop, A., Riddell, A. M., Murray, I., Du, Y., Chua, S. C., Koh, D., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.174433 · Cited by 52
Karlstaedt, A., Barrett, M., Hu, R., Gammon, S. T., & Ky, B. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.05.008 · Cited by 51
Xie, M., Zhai, W., Cheng, S., Zhang, H., Xie, Y., & He, W. (2015) · Hematology · doi:10.1179/1607845415y.0000000033 · Cited by 49
Kahraman, D., Holstein, A., Scheffler, M., Zander, T., Nogová, L., Lammertsma, A. A., Boellaard, R., Neumaier, B., Dietlein, M., Wolf, J., et al. (2012) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3182639747 · Cited by 49
Scroggins, B. T., Matsuo, M., White, A. O., Saito, K., Munasinghe, J., Sourbier, C., Yamamoto, K., Diaz, V., Takakusagi, Y., Ichikawa, K., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1957 · Cited by 49
Hundshammer, C., Braeuer, M., Müller, C. A., Hansen, A. E., Schillmaier, M., Düwel, S., Feuerecker, B., Glaser, S. J., Haase, A., Weichert, W., et al. (2018) · Theranostics · doi:10.7150/thno.25162 · Cited by 46
Vos, J. L., Zuur, C. L., Smit, L. A., de Boer, J. P., Al‐Mamgani, A., van den Brekel, M. W. M., Haanen, J. B. A. G., & Vogel, W. V. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05610-x · Cited by 46
Obligatory role of endoplasmic reticulum in brain FDG uptake
Cossu, V., Marini, C., Piccioli, P., Rocchi, A., Bruno, S., Orengo, A. M., Emionite, L., Bauckneht, M., Grillo, F., Capitanio, S., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4254-2 · Cited by 44
Kang, F., Wang, S., Tian, F., Zhao, M., Zhang, M., Wang, Z., Li, G., Liu, C., Yang, W., Li, X., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.167924 · Cited by 42
van Berkel, A., Vriens, D., Visser, E. P., Janssen, M. J. R., Gotthardt, M., Hermus, A. R., de Geus‐Oei, L., & Timmers, H. J. L. M. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.216796 · Cited by 40
Lussey‐Lepoutre, C., Bellucci, A., Burnichon, N., Amar, L., Buffet, A., Drossart, T., Fontaine, S., Clémеnt, O., Bénit, P., Rustin, P., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04633-9 · Cited by 38
Yamamoto, K., Brender, J. R., Seki, T., Kishimoto, S., Oshima, N., Choudhuri, R., Adler, S. S., Jagoda, E. M., Saito, K., Devasahayam, N., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-0928 · Cited by 37
Lee, S. J., Kim, J. G., Lee, S.-W., Chae, Y. S., Kang, B. W., Lee, Y. J., Park, J. S., & Choi, G. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2114-0 · Cited by 37
Boers‐Sonderen, M. J., de Geus‐Oei, L., Desar, I. M. E., van der Graaf, W. T. A., Oyen, W. J. G., Ottevanger, P. B., & van Herpen, C. M. L. (2014) · Targeted Oncology · doi:10.1007/s11523-014-0309-x · Cited by 35
Shenbagam, M., & Nagarajan, S. (2020) · Biochimie · doi:10.1016/j.biochi.2020.05.005 · Cited by 34
Mitchell, K. G., Amini, B., Wang, Y., Carter, B. W., Godoy, M. C. B., Parra, E. R., Behrens, C., Villalobos, P. A., Reuben, A., Lee, J. J., et al. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02560-5 · Cited by 34
Saidi, D., Cheray, M., Osman, A. M., Stratoulias, V., Lindberg, O. R., Shen, X., Blomgren, K., & Joseph, B. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1382790 · Cited by 32
Lim, Y., Bang, J.-I., Han, S., Paeng, J. C., Lee, K.-H., Kim, J. H., Kang, G. H., Jeong, S., Park, K. J., & Kim, T. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3577-0 · Cited by 31
Staging the cognitive continuum in prodromal Alzheimer's disease with episodic memory
Moscoso, A., Silva‐Rodríguez, J., Aldrey, J. M., Cortés, J., Fernández‐Ferreiro, A., Gómez‐Lado, N., Ruibal, Á., & Aguiar, P. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.07.014 · Cited by 29
Ceriani, L., Milan, L., Virili, C., Cascione, L., Paone, G., Trimboli, P., & Giovanella, L. (2020) · Thyroid · doi:10.1089/thy.2020.0224 · Cited by 29
Avallone, A., Aloj, L., Pecori, B., Caracò, C., Stefano, A. D., Tatangelo, F., Silvestro, L., Granata, V., Bianco, F., Romano, C., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.222604 · Cited by 28
Nakamoto, R., Zaba, L. C., Liang, T., Reddy, S. A., Davidzon, G., Aparici, C. M., Nguyen, J., Moradi, F., Iagaru, A. H., & Franc, B. L. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.254482 · Cited by 28
Sieow, J. L., Penny, H. L., Gun, S. Y., Tan, L. Q., Duan, K., Yeong, J. P. S., Pang, A., Lim, D., Toh, H. C., Lim, T. K. H., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010753 · Cited by 27
Tateishi, U., Tatsumi, M., Terauchi, T., Ando, K., Niitsu, N., Kim, W. S., Suh, C., Ogura, M., & Tobinai, K. (2014) · Cancer Science · doi:10.1111/cas.12588 · Cited by 27
Choi, Y., Kang, S., Ko, S.-Y., Lee, S., Kim, J. Y., Lee, H., Song, J. E., Kim, D., Kim, E., Kim, C. H., et al. (2018) · Molecular Brain · doi:10.1186/s13041-018-0415-2 · Cited by 27
Leimgruber, A., Hickson, K., Lee, S. T., Gan, H. K., Cher, L., Sachinidis, J. I., O'Keefe, G. J., & Scott, A. M. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04706-0 · Cited by 27
Metabolic switch in cancer – Survival of the fittest
Raskov, H., Gaggar, S., Tajik, A., Orhan, A., & Gögenür, I. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.11.025 · Cited by 26
Park, S., Ha, S., Kwon, H. W., Kim, W. H., Kim, T., Oh, D., Cheon, G. J., & Bang, Y. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.182675 · Cited by 25
Soussan, M., Cyrta, J., Pouliquen, C., Chouahnia, K., Orlhac, F., Martinod, E., Eder, V., Morère, J., & Buvat, I. (2014) · Radiology · doi:10.1148/radiol.14132191 · Cited by 24
Vaarwerk, B., Breunis, W. B., Haveman, L., de Keizer, B., Jehanno, N., Borgwardt, L., van Rijn, R. R., van den Berg, H., Cohen, J. F., van Dalen, E. C., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012325.pub2 · Cited by 24
Momcilovic, M., Bailey, S. T., Lee, J. T., Zamilpa, C., Jones, A. E., Abdelhady, G., Mansfield, J. R., Francis, K. P., & Shackelford, D. B. (2018) · Journal of Visualized Experiments · doi:10.3791/57167 · Cited by 24
Zhao, Y., Liu, C., Zhang, Y., Gong, C., Li, Y., Xie, Y., Wu, B., Yang, Z., & Wang, B. (2018) · Scientific Reports · doi:10.1038/s41598-018-32745-z · Cited by 23
Dunet, V., Halkic, N., Sempoux, C. L., Demartines, N., Montemurro, M., Prior, J. O., & Schmidt, S. (2020) · European Radiology · doi:10.1007/s00330-020-07191-z · Cited by 23
Chen, S.-H., Miles, K. A., Taylor, S. A., Ganeshan, B., Rodriguez‐Justo, M., Fraioli, F., Wan, S., Afaq, A., Shortman, R. I., Walls, D., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05318-y · Cited by 23
Yang, M., Mahanty, A., Jin, C., Wong, A. N. N., & Yoo, J. S. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005199 · Cited by 23
Beinat, C., Patel, C. B., Haywood, T., Murty, S., Naya, L., Castillo, J. B., Reyes, S. T., Phillips, M., Buccino, P. J., Shen, B., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0544 · Cited by 21
Novel applications of molecular imaging to guide breast cancer therapy
Edmonds, C. E., O’Brien, S. R., Mankoff, D. A., & Pantel, A. R. (2022) · Cancer Imaging · doi:10.1186/s40644-022-00468-0 · Cited by 21
Bhoil, A., Singh, B., Singh, N., Kashyap, R. K., Watts, A., Sarika, S., & Mittal, B. R. (2014) · PubMed · doi:10.1967/s002449910136 · Cited by 20
Beinat, C., Alam, I. S., James, M. L., Srinivasan, A., & Gambhir, S. S. (2017) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1068-8 · Cited by 20
Mathew, B., Vijayasekharan, K., Shah, S. A., Purandare, N. C., Agrawal, A., Puranik, A. D., Prasad, M., Narula, G., Banavali, S. D., & Rangarajan, V. (2019) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000002927 · Cited by 20
Rodríguez‐Nieto, G., Levin, O., Hermans, L., Weerasekera, A., Sava, A. C., Haghebaert, A., Huybrechts, A., Cuypers, K., Mantini, D., Himmelreich, U., et al. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119830 · Cited by 20
Deckers, E. A., Kruijff, S., Brouwers, A. H., van der Steen, K., Hoekstra, H. J., Thompson, J. F., García, D. V., & Wevers, K. P. (2020) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2020.07.011 · Cited by 19
Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis
Ouyang, X., Han, S.-N., Zhang, J.-Y., Dioletis, E., Németh, B. T., Pacher, P., Feng, D., Bataller, R. A., Cabezas, J., Stärkel, P., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.007 · Cited by 19
Carpenter, D. J., Jacobs, C. D., Wong, T. Z., Craciunescu, O. I., & Chino, J. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.06.2506 · Cited by 19
Beinat, C., Patel, C. B., Haywood, T., Shen, B., Naya, L., Gandhi, H., Holley, D., Khalighi, M. M., Iagaru, A. H., Davidzon, G., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04687-0 · Cited by 18
Jiménez-Bonilla, J. F., Quirce, R., Martínez‐Rodríguez, I., de Arcocha-Torres, M., CARRIL, J. M., & Banzo, I. (2016) · Diagnostics · doi:10.3390/diagnostics6040036 · Cited by 17
Beinat, C., Patel, C. B., Xie, Y., & Gambhir, S. S. (2019) · Molecular Imaging and Biology · doi:10.1007/s11307-019-01353-2 · Cited by 16
Fumarate Metabolic Signature for the Detection of Reed Syndrome in Humans
Casey, R. T., McLean, M. A., Challis, B., McVeigh, T. P., Warren, A. Y., Mendil, L., Houghton, R., de Sanctis, S., Kosmoliaptsis, V., Sandford, R. N., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1729 · Cited by 16
PET response assessment in apatinib-treated radioactive iodine-refractory thyroid cancer
Wang, C., Zhang, X., Yang, X. W., Li, H. Y., Cui, R., Guan, W., Li, X., Zhu, Z., & Lin, Y. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0007 · Cited by 14
Beinat, C., Haywood, T., Chen, Y., Patel, C. B., Alam, I. S., Murty, S., & Gambhir, S. S. (2018) · Molecular Imaging and Biology · doi:10.1007/s11307-018-1194-y · Cited by 14
Clemmensen, A., Hansen, A. E., Holst, P., Schøier, C., Bisgaard, S., Johannesen, H. H., Ardenkjær‐Larsen, J. H., Kristensen, A. T., & Kjær, A. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04881-0 · Cited by 13
Maharjan, S., Sharma, P., Patel, C. D., Sharma, D. N., Dhull, V. S., Jain, S. K., Thulkar, S. P., Malhotra, A., & Kumar, R. (2013) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e3283622f0d · Cited by 12
Dag, Z. O., Yılmaz, B., Doğan, A. K., Aksan, D. U., Özkurt, H., KIZILKAYA, H. O., & Arslan, D. T. (2018) · Brachytherapy · doi:10.1016/j.brachy.2018.11.005 · Cited by 12
Wang, L., Ruan, M., Lei, B., Yan, H., Sun, X., Chang, C., Liu, L., & Xie, W. (2020) · Lung Cancer · doi:10.1016/j.lungcan.2020.10.004 · Cited by 12
Ferdinandus, J., Zaremba, A., Zimmer, L., Umutlu, L., Seifert, R., Barbato, F., Ugurel, S., Chorti, E., Grünwald, V., Herrmann, K., et al. (2022) · Cancer Imaging · doi:10.1186/s40644-022-00449-3 · Cited by 11
Qi, Q., Fox, M. S., Lim, H., Sullivan, R., Li, A., Bellyou, M., Desjardins, L., McClennan, A., Bartha, R., Hoffman, L., et al. (2022) · Molecular Imaging and Biology · doi:10.1007/s11307-022-01726-0 · Cited by 11
Choi, M. K., Choi, J. Y., Lee, J., Heo, J. S., Choi, S. H., Choi, D. W., Lee, K. T., Lee, J. K., Lee, K. H., Park, J. O., et al. (2014) · Medical Oncology · doi:10.1007/s12032-014-0023-7 · Cited by 10
New metabolic imaging tools in neuro-oncology
Corbin, Z. A. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000758 · Cited by 10
A Bio-Imaging Signature as a Predictor of Clinical Outcomes in Locally Advanced Pancreatic Cancer
Fiore, M., Taralli, S., Trecca, P., Scolozzi, V., Marinelli, L., Triumbari, E. K. A., Caputo, D. D., Angeletti, S., Ciccozzi, M., Coppola, A., et al. (2020) · Cancers · doi:10.3390/cancers12082016 · Cited by 10
Multifunctional Assessment of Non–Small Cell Lung Cancer
Calandriello, L., Larici, A. R., Leccisotti, L., del Ciello, A., Sica, G., Infante, A., Congedo, M. T., Poscia, A., Giordano, A., & Bonomo, L. (2017) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001888 · Cited by 7
Reynolds, J. C., Maass‐Moreno, R., Thomas, A., Ling, A. L., Padiernos, E., Steinberg, S. M., & Hassan, R. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.238733 · Cited by 7
Esfahani, S. A., Callahan, C. J., Rotile, N. J., Heidari, P., Mahmood, U., Caravan, P. D., Grant, A. K., & Yen, Y. (2022) · Molecular Imaging and Biology · doi:10.1007/s11307-022-01727-z · Cited by 5
Eating away T cell responses in lung cancer
Ferrara, R., & Roz, L. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20221449 · Cited by 5
Hod, N., Nalbandyan, K., Porges, T., & Lantsberg, S. (2022) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000004493 · Cited by 3
Oh, S., Youn, H., Paeng, J. C., Kim, Y., Lee, C., Choi, H., Kang, K. W., Chung, J., & Cheon, G. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169273 · Cited by 2
Barbero (2014) · doi:10.1016/j · Cited by 1
Cited by
Metabolic Reprogramming in Cancer: Implications for Immunosuppressive Microenvironment
Aden, D., Sureka, N., Zaheer, S., Chaurasia, J. K., & Zaheer, S. (2024) · Immunology · doi:10.1111/imm.13871 · Cited by 66
The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation
Acuña-Pilarte, K., & Koh, M. Y. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2025.06.005 · Cited by 64
Uncovering Porphyrin Accumulation in the Tumor Microenvironment
Adapa, S. R., Sami, A., Meshram, P. U., Ferreira, G. C., & Jiang, R. H. Y. (2024) · Genes · doi:10.3390/genes15070961 · Cited by 11
Ren, L.-K., Lu, R., Fei, X., Chen, S., Liu, P., Zhu, C., Wang, X., & Pan, Y. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05644-2 · Cited by 8
Addissouky, T. A. (2026) · Journal of Rare Diseases · doi:10.1007/s44162-026-00147-9 · Cited by 6
Metadata
- Authors
- Meng, Y., Sun, J., Zhang, G., Yu, T., & Piao, H.
- Affiliations
- Liaoning Cancer Hospital & Institute (CN)
- Corresponding author
- Yu, Tao
- Piao, Haozhe
- Venue
- Frontiers in Physiology
- Publisher
- Frontiers Media SA
- Published
- 2023-02-02
- Volume
- 14
- Pages
- 1103354-1103354
- ISSN
- 1664-042X (ISSN-L)
- PMC
- PMC9932271
- OpenAlex
- W4319036440
- Cited by
- 10
- References
- 115
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 5
- FWCI
- 0.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Physiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Fundamental Research Funds for the Central Universities
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Optical Imaging and Spectroscopy Techniques
- Keywords
- glucose metabolism, tumor progression, molecular imaging, Warburg effect, tumor microenvironment, non-invasive cancer detection, molecular probes, cell proliferation, apoptosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.